INLIF Ltd director Zeng Yongfu has filed an initial Form 3, which is the SEC’s baseline report of an insider’s share ownership when they first become a reporting person. This filing does not list any specific transactions or changes in holdings; it simply establishes reporting status.
INLIF Limited has registered up to $100,000,000 of Class A Ordinary Shares for sale in an at-the-market offering under a Sales Agreement with AC Sunshine Securities LLC.
The Sales Agent may sell shares from time to time as an agent or principal at market prices and will receive a fixed commission of 3.0% of gross proceeds. The prospectus supplement states the company had 208,400,000 Class A Ordinary Shares and 12,500,000 Class B Ordinary Shares outstanding as of the date of the supplement, and that the company completed a PIPE on February 10, 2026 issuing 202,000,000 Class A shares for gross proceeds of $32,344,240.00. The prospectus supplement discloses Nasdaq bid-price noncompliance and a compliance period through April 27, 2026. The offering proceeds are designated for general corporate purposes.
INLIF Limited entered a sales agreement for an at-the-market offering of up to $100,000,000 of its Class A ordinary shares through AC Sunshine Securities LLC as sales agent. The shares will be sold from time to time under the company’s effective Form F-3 shelf registration and a related prospectus supplement. INLIF is not required to sell any shares, and the agent is not obligated to buy shares as principal. The company will pay a 3.0% commission on gross proceeds from each sale and reimburse up to $80,000 of specified expenses.
INLIF LIMITED reported fiscal 2025 results showing solid revenue growth but a swing into loss as it invests in a strategic business shift. Net revenue rose to $18.41 million, up 16.52% from 2024, helped by $2.39 million from newly launched new energy sector-focused products, which contributed 12.98% of total revenue.
Traditional manipulator arm sales declined as production capacity was redirected, while accessories, raw materials, and scraps sales increased. Cost of revenue climbed to $14.11 million, compressing gross profit to $4.29 million and lowering gross margin to 23.33% from 28.83%.
Operating expenses jumped to $10.11 million, more than triple the prior year, driven largely by $5.14 million of share-based compensation and higher R&D spending, leading to a net loss of $5.45 million versus $1.61 million net income in 2024. Despite the loss, cash and cash equivalents increased to $6.72 million, supported by $6.87 million in net cash provided by financing activities.
INLIF Limited, a Cayman Islands holding company with operations in mainland China, files its annual report detailing strong revenue growth but a sharp move into loss and significant regulatory risks tied to the PRC.
Revenue rose from $12.61 million in 2023 to $15.80 million in 2024 and $18.41 million in 2025, but 2025 swung to a net loss of about $5.45 million, driven in part by $5.14 million of share-based compensation. The company is expanding into the new energy sector, generating $2.39 million in 2025 (12.98% of revenue), while its legacy manipulator arm sales faced capacity constraints.
The filing highlights extensive China-related risks, including CAC cybersecurity and data rules, CSRC overseas listing oversight, SAFE foreign exchange controls, potential HFCA Act delisting, dividend and capital flow restrictions, enforcement uncertainty of foreign judgments, concentrated customers and suppliers, limited insurance coverage, and the need for additional capital as operating cash flow turned negative. As of December 31, 2025, there were 6,400,000 Class A ordinary shares outstanding.
INLIF Limited completed a private PIPE financing with 12 non-U.S. investors, issuing 202,000,000 Class A ordinary shares at $0.16012 per share for total gross proceeds of $32,344,240.00 (RMB 225,617,246.12).
The shares were sold under Regulation S and Section 4(a)(2), with each investor subject to a six-month lock-up from February 8, 2026. After closing on February 10, 2026, the company has 208,400,000 Class A and 12,500,000 Class B ordinary shares outstanding. Proceeds are intended for general corporate purposes, including working capital.
INLIF LIMITED reports the voting results of its 2026 Extraordinary General Meeting of Shareholders held on January 9, 2026 in Quanzhou, China. Shareholders of 6,400,000 Class A Ordinary Shares, with one vote per share, and 12,500,000 Class B Ordinary Shares, with twenty votes per share, were entitled to vote as of the December 8, 2025 record date. A quorum was present, with holders of 214,378 Class A Ordinary Shares and all 12,500,000 Class B Ordinary Shares represented, exceeding one-third of the total Ordinary Shares entitled to vote and constituting a quorum. Five resolutions were adopted, with each proposal receiving 250,000,000 votes from Class B Ordinary Shares cast "for" and relatively small Class A vote totals split between "for" and "against," plus limited abstentions.
INLIF LIMITED, a foreign private issuer based in the People’s Republic of China, filed a report to distribute materials for an upcoming Extraordinary General Meeting of Shareholders. The filing states that the company is providing the official notice and proxy statement for the meeting, along with a proxy card for shareholders to use to vote on the matters to be presented.
These documents are being mailed to shareholders and are incorporated by reference, meaning they are treated as part of this report. The report is signed on behalf of the company by its Chief Executive Officer, Rongjun Xu.
INLIF Limited reported it received a Nasdaq notice for not meeting the $1.00 minimum bid price after 30 consecutive business days between September 11 and October 24, 2025. The shares continue to trade on Nasdaq under “INLF,” and business operations are unaffected.
The company has 180 calendar days, until April 27, 2026, to regain compliance. If the closing bid price is at least $1.00 for 10 consecutive business days within this window, Nasdaq will confirm compliance. If needed, INLIF may be eligible for an additional 180-day period, subject to meeting other listing standards and notifying Nasdaq of plans to cure, which could include a reverse stock split.